Short answer: landed cost, not unit price
If you're comparing face cleanser suppliers by unit price, you're going to lose money within the first two restocks. The only number worth comparing is landed cost — what a unit actually costs you once sample round-trips, reformulation, MOQ commitments, compliance paperwork, and rework exposure are priced in. A 5–15% spread on the per-unit quote across gentle facial cleanser, sensitive-skin formulas, men's cleansers, and hydrating facial cleanser lines is noise.
I run procurement for a 180-person personal care brand. I've managed our contract manufacturing and packaging budget — about $420,000 a year — for the past six years, negotiated with 20+ OEM/ODM suppliers, and logged every order in our cost tracking system since 2019. Here's the framework I actually use, and where the cheap quotes fall apart.
Why I stopped ranking vendors by unit price
For the first two years I just sorted quotes by line-item price. That worked fine — until Q2 2023, when I audited our spend and found something uncomfortable. That year we'd switched face cleanser suppliers twice. Both had quoted lower than the incumbent.
Vendor A came in 6% under. Then we discovered their 5,000-unit MOQ didn't match our actual sell-through, we sat on four months of inventory, and ran a repackaging cycle to move stock before it went stale. Vendor B undercut us by 11% per unit — until the delivered 20,000 units showed emulsion stability drift versus the approved sample. Rework: $3,400, plus an expedited replacement run, plus two channel customers who quietly stopped reordering.
Net result: two "cheaper" quotes, and I ended up spending 4.8% more than the original vendor for those two quarters — while burning a month of team time I never got back.
The four costs the cheap quote leaves out
Most buyers focus on per-unit pricing and completely miss sample iteration, MOQ flexibility, compliance documentation, and rework risk. Those four are what turn a 6% line-item saving into a net loss.
1. Sample iteration
Low-cost suppliers usually don't nail the first sample. For a gentle facial cleanser it's not unusual to run three iterations before the texture, pH, and rinse feel match spec. Sensitive-skin formulas are harder — every surfactant swap reopens stability testing. Hydrating facial cleanser briefs with a specific after-feel are worse still. Each iteration costs 10–21 days and $80–$250 in samples and freight, depending on the base.
2. MOQ and lead-time flexibility
Cheap quotes almost always come with a higher minimum order and a longer locked-in window. If your sell-through doesn't match the MOQ, you're not saving money — you're pre-buying inventory. Carrying cost in our category runs 8–12% a year once you count storage and working capital. That eats the discount fast.
3. Compliance and documentation
If you're selling into the US, your supplier has to support the claims on your label. Per FTC advertising guidance, claims must be truthful, substantiated with evidence, and not misleading — including on packaging. Stability data, microbial testing, and ingredient disclosures aren't optional add-ons. When a supplier can't produce them, every delayed batch carries detention fees, retailer chargebacks, and brand risk that dwarfs the unit-price gap.
4. Rework and recall exposure
When a formulation or fill goes wrong, you don't rework one batch. You rework the line, expedite replacements, and eat the gap with your channel. In our category a single mid-size recall event has cost peers I know anywhere from $40,000 to mid-six figures — before legal.
What the TCO model looks like in practice
After getting burned twice on hidden fees, I built a TCO spreadsheet that I refresh every quarter. It has one column per vendor and four cost buckets: quoted materials + fill, iteration and sample cost, MOQ-driven carrying cost, and a weighted rework probability (based on that vendor's last six months of QC data).
I don't guess those probabilities. First three orders with any new supplier are tracked line by line, then back-filled into the model. After two quarters you can predict the hidden-cost range from the quote structure alone — anyone quoting 20% under market with a 10,000 MOQ and no stability timeline is a known quantity.
This gets into regulatory territory that isn't my expertise. I'd recommend a regulatory consultant before finalizing anything aimed at sensitive-skin or men's categories in the EU or UK, where the claim review is tighter than you'd expect.
Where the low quote actually wins
I'm not saying cheap is always wrong. There's one scenario where the low quote genuinely is the best deal: stable, locked formula; standardized packaging; batch size large enough (50,000 units and up, in our category) that the MOQ risk flattens out; and at least 3 clean production runs with that factory. Under those specific conditions the hidden-cost buckets compress and the unit-price gap becomes real money.
The 'low quote always wins' mindset comes from an era when most brands ran one cleanser SKU with one formulation. That's changed. If you're launching a men's line, a sensitive-skin variant, or a hydrating facial cleanser under a legacy brand, the buyer's job isn't to find the lowest number — it's to decide how much uncertainty you can afford per unit.
I'm not a formulation chemist, so I can't tell you whether a particular amino-acid surfactant system will hold its pH across a 24-month shelf life. What I can tell you from a procurement perspective is how to price that uncertainty before you sign the PO.
Bottom line: you're not buying cleanser per unit. You're buying formulation certainty, delivery certainty, and compliance certainty. None of those are on the quote sheet — but every one of them shows up on the P&L.